Gut-Brain-Axis/Lung-Brain-Axis and Mental Ill Health in Critical Illness
1 other identifier
observational
60
1 country
1
Brief Summary
Survivors of critical illness commonly experience long-lasting cognitive, mental health and physical impairments. Clinically significant symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD) may occur in 40%, 34% and 20% of ICU survivors respectively, compared to 6%, 8% and 4% in the general population. These symptoms can persist for more than 8 years. Evidence shows the existence of a two-way, communication network between gut microbes and the brain referred to as the gut-brain axis. Changes in the microbiome and dysregulation of this communication network in relatively healthy people is associated with cognitive dysfunction and mood disorders such as anxiety and depression. The physiological stress associated with critical illness itself and many ICU interventions including the use of mechanical ventilation and medications such as antibiotics, antacids, vasopressors, and steroids can influence the balance of the gut microbiome and associated metabolites. This observation study aims to:
- 1.Quantify and measure dynamic changes in the gut microbiome and its metabolites during critical illness and recovery.
- 2.Explore the associations between microbiome and metabolomic changes during critical illness and psychological symptoms in the patient during their recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2022
CompletedFirst Posted
Study publicly available on registry
October 14, 2022
CompletedStudy Start
First participant enrolled
February 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedApril 14, 2023
April 1, 2023
1.7 years
October 11, 2022
April 12, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Gut microbiome changes
Quantify and measure dynamic changes in the gut microbiome and its metabolites during critical illness and recovery. (The number and diversity of microbe present)
3 months post-discharge
Microbiome, metabolic changes and psychological symptoms
Explore the associations between microbiome and metabolomic changes during critical illness and psychological symptoms in the patient during their recovery.
3 months post-discharge
Gut microbial and metabolic signatures
Investigate the potential for gut microbial and metabolic signatures at admission and discharge to predict the future development of psychological symptoms following ICU discharge.
3 months post-discharge
Sample repository
Establish a sample repository for future analysis for future studies.
3 months post-discharge
Eligibility Criteria
Patients with an unplanned admission to critical care who are mechanically ventilated
You may qualify if:
- Unplanned admission to critical care
- Aged ≥18 years old
- Requiring mechanical ventilation
- Commencing ventilation within the previous 24 hours
- Expected to be ventilated for minimum of ≥72 hours
You may not qualify if:
- Known prior diagnosis of cognitive impairment
- Known prior mental ill health
- Known malignancy
- Admitted after presenting with any of the following conditions:
- trauma
- brain injury
- surgery
- cardiac arrest
- immunosuppressed
- underlying pyogenic infection
- Not expected to survive to completion of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2022
First Posted
October 14, 2022
Study Start
February 14, 2023
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
April 14, 2023
Record last verified: 2023-04